The Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.12), $0.10 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $71.1 million.

GUIDANCE:

The Beauty Health Company sees 2022 revenue of $320-330 million, versus the consensus of $314 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.